ENSG00000105568 |
|
Endometrial Clear Cell Adenocarcinoma |
sequence_alteration |
16.07% (18/112) |
2 entries |
ENSG00000105568 |
|
Endometrial Clear Cell Adenocarcinoma |
missense_variant |
16.07% (18/112) |
4 entries |
ENSG00000105568 |
|
endometrium adenocarcinoma |
missense_variant |
17.95% (7/39) |
5 entries |
ENSG00000105568 |
|
colorectal adenocarcinoma |
frameshift_variant |
3.987% (48/1204) |
2 entries |
ENSG00000105568 |
|
lung carcinoma |
missense_variant |
8.955% (12/134) |
1 entry |
ENSG00000105568 |
|
ovarian clear cell adenocarcinoma |
missense_variant |
7.54% (19/252) |
7 entries |
ENSG00000105568 |
|
lung carcinoma |
sequence_alteration |
8.955% (12/134) |
1 entry |
ENSG00000105568 |
|
Uterine Carcinosarcoma |
sequence_alteration |
9.91% (22/222) |
3 entries |
ENSG00000105568 |
|
endometrial carcinoma |
sequence_alteration |
30.14% (66/219) |
6 entries |
ENSG00000105568 |
|
Endometrial Endometrioid Adenocarcinoma |
sequence_alteration |
5.516% (69/1251) |
2 entries |
ENSG00000105568 |
|
endometrial carcinoma |
missense_variant |
30.14% (66/219) |
7 entries |
ENSG00000105568 |
|
Uterine Carcinosarcoma |
missense_variant |
9.91% (22/222) |
3 entries |
ENSG00000105568 |
|
Endometrial Endometrioid Adenocarcinoma |
missense_variant |
5.516% (69/1251) |
6 entries |
ENSG00000105568 |
|
colorectal adenocarcinoma |
sequence_alteration |
3.987% (48/1204) |
2 entries |
ENSG00000105568 |
|
colorectal adenocarcinoma |
missense_variant |
3.987% (48/1204) |
3 entries |
ENSG00000105568 |
|
prostate adenocarcinoma |
missense_variant |
1.297% (28/2158) |
3 entries |
ENSG00000105568 |
|
skin melanoma |
missense_variant |
1.105% (13/1176) |
4 entries |
ENSG00000105568 |
|
female breast carcinoma |
missense_variant |
0.3745% (2/534) |
1 entry |
ENSG00000105568 |
|
esophageal squamous cell carcinoma |
sequence_alteration |
1.02% (7/686) |
2 entries |
ENSG00000105568 |
|
Gastrointestinal stromal tumor |
missense_variant |
1.974% (3/152) |
1 entry |
ENSG00000105568 |
|
Ovarian Endometrioid Adenocarcinoma |
missense_variant |
6.471% (11/170) |
4 entries |
ENSG00000105568 |
|
hemangioblastoma |
sequence_alteration |
11.43% (4/35) |
1 entry |
ENSG00000105568 |
|
clear cell renal carcinoma |
sequence_alteration |
0.3219% (6/1864) |
2 entries |
ENSG00000105568 |
|
Vulvar Squamous Cell Carcinoma |
missense_variant |
2.679% (3/112) |
1 entry |
ENSG00000105568 |
|
breast carcinoma |
missense_variant |
0.5161% (8/1550) |
3 entries |
ENSG00000105568 |
|
colon adenocarcinoma |
sequence_alteration |
2.243% (29/1293) |
4 entries |
ENSG00000105568 |
|
brain glioblastoma |
missense_variant |
0.495% (6/1212) |
1 entry |
ENSG00000105568 |
|
breast ductal adenocarcinoma |
missense_variant |
1.563% (25/1599) |
1 entry |
ENSG00000105568 |
|
prostate carcinoma |
sequence_alteration |
0.6198% (3/484) |
1 entry |
ENSG00000105568 |
|
gastric adenocarcinoma |
sequence_alteration |
1.427% (12/841) |
2 entries |
ENSG00000105568 |
|
esophageal adenocarcinoma |
sequence_alteration |
2.19% (12/548) |
1 entry |
ENSG00000105568 |
|
Endometrial Endometrioid Adenocarcinoma |
conservative_inframe_deletion |
5.516% (69/1251) |
1 entry |
ENSG00000105568 |
|
colon carcinoma |
missense_variant |
25.0% (2/8) |
1 entry |
ENSG00000105568 |
|
esophageal squamous cell carcinoma |
missense_variant |
1.02% (7/686) |
3 entries |
ENSG00000105568 |
|
large cell lung carcinoma |
missense_variant |
21.05% (4/19) |
3 entries |
ENSG00000105568 |
|
Extramammary Paget Disease |
missense_variant |
66.67% (2/3) |
2 entries |
ENSG00000105568 |
|
ovarian serous adenocarcinoma |
missense_variant |
0.8696% (10/1150) |
4 entries |
ENSG00000105568 |
|
squamous cell lung carcinoma |
missense_variant |
1.406% (14/996) |
3 entries |
ENSG00000105568 |
|
skin melanoma |
stop_gained |
1.105% (13/1176) |
1 entry |
ENSG00000105568 |
|
colon adenocarcinoma |
missense_variant |
2.243% (29/1293) |
6 entries |
ENSG00000105568 |
|
Endometrial Undifferentiated Carcinoma |
missense_variant |
10.87% (5/46) |
2 entries |
ENSG00000105568 |
|
Mixed Lobular and Ductal Breast Carcinoma |
missense_variant |
3.125% (2/64) |
1 entry |
ENSG00000105568 |
|
brain glioblastoma |
frameshift_variant |
0.495% (6/1212) |
1 entry |
ENSG00000105568 |
|
pancreatic ductal adenocarcinoma |
missense_variant |
1.281% (22/1718) |
3 entries |
ENSG00000105568 |
|
rectal adenocarcinoma |
missense_variant |
0.9158% (5/546) |
1 entry |
ENSG00000105568 |
|
HER2 Positive Breast Carcinoma |
stop_gained |
2.128% (4/188) |
1 entry |
ENSG00000105568 |
|
cecum adenocarcinoma |
missense_variant |
1.852% (5/270) |
2 entries |
ENSG00000105568 |
|
large cell lung carcinoma |
sequence_alteration |
21.05% (4/19) |
3 entries |
ENSG00000105568 |
|
skin melanoma |
sequence_alteration |
1.105% (13/1176) |
2 entries |
ENSG00000105568 |
|
lung adenocarcinoma |
missense_variant |
1.156% (30/2595) |
4 entries |
ENSG00000105568 |
|
breast carcinoma |
sequence_alteration |
0.5161% (8/1550) |
3 entries |
ENSG00000105568 |
|
gastric adenocarcinoma |
missense_variant |
1.427% (12/841) |
2 entries |
ENSG00000105568 |
|
prostate adenocarcinoma |
sequence_alteration |
1.297% (28/2158) |
2 entries |
ENSG00000105568 |
|
ovarian serous adenocarcinoma |
sequence_alteration |
0.8696% (10/1150) |
2 entries |
ENSG00000105568 |
|
Ovarian Endometrioid Adenocarcinoma |
sequence_alteration |
6.471% (11/170) |
2 entries |
ENSG00000105568 |
|
Extramammary Paget Disease |
sequence_alteration |
66.67% (2/3) |
2 entries |
ENSG00000105568 |
|
ovarian mucinous adenocarcinoma |
missense_variant |
2.174% (2/92) |
1 entry |
ENSG00000105568 |
|
lung adenocarcinoma |
sequence_alteration |
1.156% (30/2595) |
2 entries |
ENSG00000105568 |
|
Gallbladder Adenocarcinoma |
sequence_alteration |
1.212% (2/165) |
1 entry |
ENSG00000105568 |
|
hepatocellular carcinoma |
missense_variant |
0.8122% (8/985) |
1 entry |
ENSG00000105568 |
|
rectal adenocarcinoma |
sequence_alteration |
0.9158% (5/546) |
1 entry |
ENSG00000105568 |
|
brain glioblastoma |
sequence_alteration |
0.495% (6/1212) |
3 entries |
ENSG00000105568 |
|
Thyroid Gland Undifferentiated (Anaplastic) Carcinoma |
missense_variant |
1.136% (3/264) |
1 entry |
ENSG00000105568 |
|
bladder transitional cell carcinoma |
missense_variant |
1.728% (8/463) |
1 entry |
ENSG00000105568 |
|
colon adenocarcinoma |
frameshift_variant |
2.243% (29/1293) |
1 entry |
ENSG00000105568 |
|
non-small cell lung carcinoma |
sequence_alteration |
0.8772% (1/114) |
1 entry |
ENSG00000105568 |
|
bile duct adenocarcinoma |
missense_variant |
0.2551% (1/392) |
1 entry |
ENSG00000105568 |
|
oral squamous cell carcinoma |
missense_variant |
0.3817% (1/262) |
1 entry |
ENSG00000105568 |
|
Pleural Epithelioid Mesothelioma |
sequence_alteration |
0.5% (1/200) |
1 entry |
ENSG00000105568 |
|
ovarian adenocarcinoma |
missense_variant |
16.67% (1/6) |
1 entry |
ENSG00000105568 |
|
Appendix Adenocarcinoma |
missense_variant |
1.351% (1/74) |
1 entry |
ENSG00000105568 |
|
pharyngeal squamous cell carcinoma |
missense_variant |
1.235% (1/81) |
1 entry |
ENSG00000105568 |
|
hemangioblastoma |
missense_variant |
11.43% (4/35) |
1 entry |
ENSG00000105568 |
|
pharyngeal squamous cell carcinoma |
sequence_alteration |
1.235% (1/81) |
1 entry |
ENSG00000105568 |
|
urothelial carcinoma |
sequence_alteration |
1.163% (1/86) |
1 entry |
ENSG00000105568 |
|
astrocytoma |
missense_variant |
14.29% (1/7) |
1 entry |
ENSG00000105568 |
|
rectal adenocarcinoma |
stop_gained |
0.9158% (5/546) |
1 entry |
ENSG00000105568 |
|
basal cell carcinoma |
missense_variant |
1.471% (1/68) |
1 entry |
ENSG00000105568 |
|
small intestinal adenocarcinoma |
missense_variant |
4.762% (1/21) |
1 entry |
ENSG00000105568 |
|
Bladder Adenocarcinoma |
missense_variant |
14.29% (1/7) |
1 entry |
ENSG00000105568 |
|
Borderline Ovarian Surface Epithelial-Stromal Tumor |
missense_variant |
100.0% (1/1) |
1 entry |
ENSG00000105568 |
|
diffuse gastric adenocarcinoma |
missense_variant |
1.22% (1/82) |
1 entry |
ENSG00000105568 |
|
pancreatic neuroendocrine tumor |
missense_variant |
2.119% (5/236) |
1 entry |
ENSG00000105568 |
|
Endometrial Undifferentiated Carcinoma |
sequence_alteration |
10.87% (5/46) |
1 entry |
ENSG00000105568 |
|
lobular breast carcinoma |
missense_variant |
0.4202% (1/238) |
1 entry |
ENSG00000105568 |
|
small cell lung carcinoma |
missense_variant |
0.2242% (1/446) |
1 entry |
ENSG00000105568 |
|
Duodenal Adenocarcinoma |
missense_variant |
5.882% (1/17) |
1 entry |
ENSG00000105568 |
|
urothelial carcinoma |
missense_variant |
1.163% (1/86) |
1 entry |
ENSG00000105568 |
|
colon adenocarcinoma |
stop_gained |
2.243% (29/1293) |
1 entry |
ENSG00000105568 |
|
esophageal adenocarcinoma |
missense_variant |
2.19% (12/548) |
1 entry |
ENSG00000105568 |
|
papillary thyroid carcinoma |
missense_variant |
0.1938% (1/516) |
1 entry |
ENSG00000105568 |
|
neoplasm |
sequence_alteration |
3.448% (1/29) |
1 entry |
ENSG00000105568 |
|
small cell lung carcinoma |
sequence_alteration |
0.2242% (1/446) |
1 entry |
ENSG00000105568 |
|
cecum adenocarcinoma |
sequence_alteration |
1.852% (5/270) |
1 entry |
ENSG00000105568 |
|
breast carcinoma |
frameshift_variant |
0.5161% (8/1550) |
1 entry |
ENSG00000105568 |
|
Gallbladder Adenocarcinoma |
missense_variant |
1.212% (2/165) |
1 entry |
ENSG00000105568 |
|
chronic myelomonocytic leukemia |
missense_variant |
3.704% (1/27) |
1 entry |
ENSG00000105568 |
|
female breast carcinoma |
sequence_alteration |
0.3745% (2/534) |
1 entry |
ENSG00000105568 |
|
oral squamous cell carcinoma |
sequence_alteration |
0.3817% (1/262) |
1 entry |
ENSG00000105568 |
|
basal cell carcinoma |
sequence_alteration |
1.471% (1/68) |
1 entry |
ENSG00000105568 |
|
gastric intestinal type adenocarcinoma |
sequence_alteration |
1.176% (1/85) |
1 entry |
ENSG00000105568 |
|
mucosal melanoma |
sequence_alteration |
1.429% (1/70) |
1 entry |
ENSG00000105568 |
|
pancreatic ductal adenocarcinoma |
frameshift_variant |
1.281% (22/1718) |
1 entry |
ENSG00000105568 |
|
melanoma |
missense_variant |
0.6897% (1/145) |
1 entry |
ENSG00000105568 |
|
Maxillary Sinus Adenoid Cystic Carcinoma |
missense_variant |
100.0% (1/1) |
1 entry |
ENSG00000105568 |
|
astrocytoma |
sequence_alteration |
14.29% (1/7) |
1 entry |
ENSG00000105568 |
|
undifferentiated pleomorphic sarcoma |
missense_variant |
1.613% (1/62) |
1 entry |
ENSG00000105568 |
|
breast ductal adenocarcinoma |
conservative_inframe_deletion |
1.563% (25/1599) |
1 entry |
ENSG00000105568 |
|
Cervical Clear Cell Adenocarcinoma |
missense_variant |
100.0% (1/1) |
1 entry |
ENSG00000105568 |
|
mucosal melanoma |
missense_variant |
1.429% (1/70) |
1 entry |
ENSG00000105568 |
|
clear cell renal carcinoma |
frameshift_variant |
0.3219% (6/1864) |
1 entry |
ENSG00000105568 |
|
rhabdomyosarcoma |
missense_variant |
2.778% (1/36) |
1 entry |
ENSG00000105568 |
|
diffuse gastric adenocarcinoma |
sequence_alteration |
1.22% (1/82) |
1 entry |
ENSG00000105568 |
|
chronic myelomonocytic leukemia |
sequence_alteration |
3.704% (1/27) |
1 entry |
ENSG00000105568 |
|
Thymoma Type B3 |
missense_variant |
8.333% (1/12) |
1 entry |
ENSG00000105568 |
|
Pleural Epithelioid Mesothelioma |
missense_variant |
0.5% (1/200) |
1 entry |
ENSG00000105568 |
|
ovarian adenocarcinoma |
sequence_alteration |
16.67% (1/6) |
1 entry |
ENSG00000105568 |
|
gastric intestinal type adenocarcinoma |
stop_gained |
1.176% (1/85) |
1 entry |
ENSG00000105568 |
|
rhabdomyosarcoma |
sequence_alteration |
2.778% (1/36) |
1 entry |
ENSG00000105568 |
|
non-small cell lung carcinoma |
missense_variant |
0.8772% (1/114) |
1 entry |
ENSG00000105568 |
|
major salivary gland adenoid cystic carcinoma |
missense_variant |
4.0% (1/25) |
1 entry |